Kura Oncology Inc (KURA)
18.02
+0.20
(+1.12%)
USD |
NASDAQ |
Nov 05, 09:44
Kura Oncology Price to Book Value: 2.963 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 2.930 |
| November 01, 2024 | 2.776 |
| October 31, 2024 | 2.749 |
| October 30, 2024 | 2.790 |
| October 29, 2024 | 2.854 |
| October 28, 2024 | 2.915 |
| October 25, 2024 | 2.879 |
| October 24, 2024 | 2.924 |
| October 23, 2024 | 2.798 |
| October 22, 2024 | 2.856 |
| October 21, 2024 | 2.910 |
| October 18, 2024 | 2.960 |
| October 17, 2024 | 2.974 |
| October 16, 2024 | 3.004 |
| October 15, 2024 | 2.994 |
| October 14, 2024 | 2.970 |
| October 11, 2024 | 3.055 |
| October 10, 2024 | 2.999 |
| October 09, 2024 | 3.012 |
| October 08, 2024 | 2.986 |
| October 07, 2024 | 2.942 |
| October 04, 2024 | 2.966 |
| October 03, 2024 | 2.989 |
| October 02, 2024 | 3.042 |
| October 01, 2024 | 3.159 |
| Date | Value |
|---|---|
| September 30, 2024 | 3.213 |
| September 27, 2024 | 3.210 |
| September 26, 2024 | 3.200 |
| September 25, 2024 | 3.218 |
| September 24, 2024 | 3.259 |
| September 23, 2024 | 3.323 |
| September 20, 2024 | 3.445 |
| September 19, 2024 | 3.466 |
| September 18, 2024 | 3.331 |
| September 17, 2024 | 3.315 |
| September 16, 2024 | 3.432 |
| September 13, 2024 | 3.433 |
| September 12, 2024 | 3.270 |
| September 11, 2024 | 3.269 |
| September 10, 2024 | 3.246 |
| September 09, 2024 | 3.216 |
| September 06, 2024 | 3.172 |
| September 05, 2024 | 3.236 |
| September 04, 2024 | 3.262 |
| September 03, 2024 | 3.323 |
| August 30, 2024 | 3.463 |
| August 29, 2024 | 3.372 |
| August 28, 2024 | 3.312 |
| August 27, 2024 | 3.335 |
| August 26, 2024 | 3.377 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.309
Minimum
Oct 23 2023
8.967
Maximum
Dec 11 2020
2.812
Average
2.458
Median
Jul 20 2022
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.666 |
| Perspective Therapeutics Inc | 2.412 |
| Protalix BioTherapeutics Inc | 3.294 |
| Electromed Inc | 4.416 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 18.02 |
| Earnings Yield | -12.38% |
| Market Cap | 1.381B |